Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Following a major outbreak involving the use of tear drops in 13 US states, experts are offering advice on how to protect dry eyes.
Read Full NewsThe U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet to treat infestations caused by the New World screwworm...
Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.
A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.
A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.
Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.
Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...
Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World Health Organization said, as the outbreak of the dangerous...
1.
Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.
2.
All-Oral Treatment Combo for AML Earns FDA Nod
3.
Herpes virus-based vaccine shows promise in targeting tumors without side effects
4.
Effects of Recombinant Replacement Therapy Explained in Detailed Regarding Genetic Clotting Disorder.
5.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
1.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
2.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
3.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
4.
Gender-Specific Dual Antiplatelet Therapy Strategies for Women After PCI
5.
Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Navigating the Complexities of Ph Negative ALL - Part XIV
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge